Clinical Trials Directory

Trials / Completed

CompletedNCT02801409

Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer Surgery

Effects of Epidural Anesthesia-analgesia on Long-term Survival in Patients After Lung Cancer Surgery: A Randomized Controlled Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
400 (actual)
Sponsor
Peking University First Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Available studies suggest that regional anesthesia-analgesia may decrease the occurrence of recurrence/metastasis in patients after cancer surgery. However, evidences from prospective studies are still lacking. The purpose of this randomized controlled trial is to investigate the effect of epidural anesthesia-analgesia on recurrence-free survival in patients undergoing lung cancer surgery.

Detailed description

Lung cancer is increasing and is the leading cause of cancer death. Surgical resection is the mainstay of treatment for early stage non-small cell lung cancer. However, long-term survival after lung cancer surgery is far from optimal, and cancer recurrence or metastasis is the main reason leading to cancer death in these patients. The development of cancer recurrence/metastasis largely depends on the balance between tumor-promoting factors and immune function of the body. Studies showed that surgical manipulation releases cancer cells into circulation; and stress response induced by surgery inhibits the cell-mediated immunity. In addition, volatile anesthetics and opioids may also aggravate immunosuppression and potentially worsen long-term outcome. On the other hand, regional anesthesia can blunt surgical stress and reduce anesthetic consumption. These effects may help to preserve immune function and reduce recurrence/metastasis. However, existing evidences are insufficient to draw conclusion in this topic. The purpose of this randomized controlled trial is to test the hypothesize that regional anesthesia-analgesia may reduce recurrence/metastasis and improve long-term survival in patients after lung cancer surgery.

Conditions

Interventions

TypeNameDescription
DRUGGeneral anesthesia aloneGeneral anesthesia is performed during surgery; patient-controlled intravenous analgesia is provided after surgery.
DRUGCombined epidural-general anesthesiaCombined epidural-general anesthesia is performed during surgery; patient-controlled epidural analgesia is provided after surgery.

Timeline

Start date
2015-05-25
Primary completion
2017-11-11
Completion
2019-11-30
First posted
2016-06-15
Last updated
2020-08-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02801409. Inclusion in this directory is not an endorsement.